Cell surface protein glycosylation in cancer

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Protein glycosylation is a vital post-translational modification (PTM) affecting over half of human proteins.
• Aberrant glycosylation is linked to disease pathogenesis, impacting protein folding and biological function.
• In cancer, altered cell surface glycosylation, especially terminal motifs, promotes tumor invasion and metastasis.

Purpose of the Study:

• To provide a comprehensive review of structural glycosylation changes and associated enzymes in five major cancer types: breast, colon, liver, skin, and ovary.
• To identify key similarities and differences in glycosylation patterns across these cancers.
• To explore the potential of these glycan alterations as diagnostic and prognostic cancer biomarkers.

Main Methods:

• Literature review focusing on structural changes in N- and O-glycans.
• Analysis of associated synthetic enzymes, particularly glycosyltransferases.
• Comparative analysis across breast, colon, liver, skin, and ovarian cancers.

Main Results:

• Detailed overview of structural glycan alterations (sialylation, fucosylation, branching) in the studied cancers.
• Identification of specific glycosyltransferase expression patterns relevant to each cancer type.
• Highlighting common and distinct glycosylation features across the five cancers.

Conclusions:

• Structural changes in cell surface glycans and their synthetic enzymes play a significant role in cancer progression.
• Understanding these alterations can reveal crucial similarities and differences between various cancer types.
• Glycan-based biomarkers hold promise for improved cancer diagnosis and prognosis.